$1 Billion Global Market for Oxygen Therapy and Inhalation Devices Driven by High Prevalence of Respiratory Disease and Shift to Home and Alternative Care Settings
Disease Demographics, Technological Trends and Cost Reduction Initiatives Are Impacting Market Growth, According to Life Science Intelligence
HUNTINGTON BEACH, Calif., June 11, 2015 /PRNewswire/ -- According to newly released analyses from Life Science Intelligence, the U.S., European, Asia-Pacific and rest-of-world (ROW) markets for oxygen therapy products and inhalation devices is forecast to exceed $1.1 billion in sales by 2020. According to the study, growth in developed markets, such as the U.S., has been profoundly shaped by trends in reimbursement. While cost-containment efforts by providers have threatened product manufacturers' margins, they have also spurred the adoption of technologies that reduce the need for frequent visits and facilitate more flexible lifestyles for patients, trends which will not only have important consequences in developed markets but could alter the competitive landscape in emerging markets. The new study analyzes and forecasts the global markets for stationary, ambulatory/portable, and transfilling oxygen concentrators; liquid oxygen systems; cylinders; dry powder inhalers; metered dose inhalers; nebulizers; and patient consumables. According to the report, the U.S. represents the largest market for these products, although countries in the Asia-Pacific and ROW regions with evolving healthcare systems are expected to offer significant opportunities for product suppliers and generate the fastest growth rates through 2020.
Leading suppliers of oxygen therapy systems and inhalation devices that are covered in Life Science Intelligence's newly published Report, "Global Markets for Oxygen Therapy and Inhalation Devices," include Philips Respironics, Invacare, Chart Industries, DeVilbiss Healthcare, Inogen, Aerogen, CareFusion, Clement Clarke International, Intersurgical, Medquip, Monaghan Medical, Nidek Medical, nSpire Health, 02 Concepts, PARI Respiratory Equipment, Respiratory Delivery Systems, Salter Labs, Smiths Medical, Thayer Medical, and Westmed, among others.
For additional details or to obtain a copy of this new study, visit here or contact LSI.
Contact:
Scott Pantel
[email protected]
714 847 3540
About Life Science Intelligence
Life Science Intelligence (LSI) delivers high-quality global market intelligence products to medical technology executives, entrepreneurs, and investors. LSI provides custom research services, publishes global market reports and procedure volume databases, tracks emerging medtech companies, and hosts the annual Emerging Medical Technologies Summit.
Logo - http://photos.prnewswire.com/prnh/20150611/222528LOGO
SOURCE Life Science Intelligence
Share this article